Florida Licenses Provista Dx for Clinical Lab Services | GenomeWeb

NEW YORK (GenomeWeb News) – Florida has licensed Provista Diagnostics to offer clinical laboratory services for patient samples originating within the state, the company said today.

The Scottsdale, Ariz.-based molecular diagnostic firm received the Out of State Laboratory License from the Clinical Laboratory Unit of the Florida Agency for Healthcare Administration. As a result, Provista can now offer its clinical lab services to 49 of the 50 states in the US, with New York being the exception.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.